Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • Cumberland Pharmaceuticals' Return on Invested Capital rose 2600.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.22% for FY2024, which is 700.0% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Return on Invested Capital of 0.12% as of Q3 2025, which was up 2600.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Return on Invested Capital registered a high of 0.1% during Q2 2021, and its lowest value of 0.41% during Q2 2024.
  • In the last 5 years, Cumberland Pharmaceuticals' Return on Invested Capital had a median value of 0.17% in 2023 and averaged 0.19%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -2900bps in 2024, then soared by 3000bps in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.17% in 2021, then grew by 11bps to 0.15% in 2022, then tumbled by -91bps to 0.29% in 2023, then increased by 26bps to 0.22% in 2024, then skyrocketed by 45bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.1% for Q2 2025, and 0.11% during Q1 2025.